Levocetirizine (Xitolec Fc, Xitolec, Cetaway)
Levocetirizine
Abex Pharmaceutica (Pty) Ltd
Registration
- Applicant
- Abex Pharmaceutica (Pty) Ltd
- Registrations
- 3
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Xitolec fc Each Tablet Contains: Levocetirizine Dihydrochloride 5,0mg | Not listed | 47095047/5.7.1/0950 | Registered | Not determined | None |
| Xitolec solution Each 1,0 ml solution contains :LEVOCETIRIZINE DIHYDROCHLORIDE 0,5 mg | Solution | 47095247/5.7.1/0952 | Registered | Not determined | None |
| Cetaway solution EACH 1,0 ML SOLUTION CONTAINS: LEVOCETIRIZINE DIHYDROCHLORIDE 0,5 mg | Solution | 470953.095247/5.7.1/0953.952 | Registered | Not determined | None |
Regulatory status
This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.
Listings for this ingredient that could not be applied to this product
S1: Levocetirizine
Consolidated Schedules 06 July 2026, line 775
3 of 9 approved products with this ingredient carry S2 on their leaflet.
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
No structure available
This product's active ingredient could not be matched to a single known compound.
SAHPRA documents
SAHPRA has not published a professional information or patient information leaflet for this product.